Identification of ZCCHC8 as fusion partner of ROS1 in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3). Issue 9 (23rd June 2016)

• Record Type: Journal Article
• Authors: Coccé, Mariela C.; Mardin, Balca R.; Bens, Susanne; Stütz, Adrian M.; Lubieniecki, Fabiana; Vater, Inga; Korbel, Jan O.; Siebert, Reiner; Alonso, Cristina N.; Gallego, Marta S.
• Is Part Of: Genes, chromosomes & cancer. Volume 55:Issue 9(2016:Sep.)
• Page Start: 677
• Page End: 687
• Publication Date: 2016-06-23
• Subjects: Cancer -- Genetic aspects -- Periodicals; 616.994042
• DOI: 10.1002/gcc.22369
• Languages: English
• ISSNs: 1045-2257

Abstract

Abstract : Congenital gliobastoma multiforme (GBM) is rare and little is known about the molecular defects underlying the initiation and progression of this tumor type. We present a case of congenital GBM analyzed by conventional cytogenetics, fluorescence in situ hybridization, array comparative genomic hybridization and next generation sequencing. On cytogenetic analysis we detected a reciprocal translocation t(6;12)(q21;q24.3). By sequencing, the translocation was shown to form a fusion between the 5′ region of ZCCHC8 and the 3′ region of ROS1 . RT‐PCR analyses confirmed the existence of an in‐frame fusion transcript with ZCCHC8 exons 1‐3 joined to ROS1 exons 36‐43. In addition to the ZCCHC8‐ROS1 fusion, we detected a deletion in the short arm of chromosome 9, including homozygous loss of the CDKN2A/2B locus in 9p21.3 and heterozygous deletion of the HAUS6 gene in 9p22.1. The latter encodes a protein involved in faithful chromosome segregation by regulating microtubule nucleation and its deletion might be associated with the marked subclonal changes of ploidy observed in the tumor. This report adds the ZCCHC8‐ROS1 fusion as oncogenic driver in GBM and supports the role of ROS1 activation in the pathogenesis of a subset of GBM. © 2016 Wiley Periodicals, Inc.